Yoga for Youth With IBD: a Pilot Feasibility Study
The Effects of Yoga on Disease Activity in Youth With Inflammatory Bowel Disease: a Pilot Feasibility Study
1 other identifier
interventional
9
1 country
1
Brief Summary
An 8-week yoga intervention to determine the feasibility and acceptability of yoga as a supplemental therapy in the management of inflammatory bowel disease in the adolescent population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2017
CompletedFirst Submitted
Initial submission to the registry
September 6, 2018
CompletedFirst Posted
Study publicly available on registry
February 17, 2021
CompletedFebruary 17, 2021
February 1, 2021
5 months
September 6, 2018
February 16, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of acceptability
Focus Group
1 hour focus group at conclusion of intervention.
Secondary Outcomes (3)
Fecal Calprotectin
6 weeks (Prior to intervention; After conclusion of intervention)
Pediatric Ulcerative Colitis Activity Index
6 weeks (Prior to intervention; After conclusion of intervention)
PROMIS-37
6 weeks (Prior to intervention; After conclusion of intervention)
Interventions
Yoga for 30 minutes three times weekly for 8 weeks in addition to three, 1-hour in-studio yoga sessions.
Eligibility Criteria
You may qualify if:
- Age 10-21
- Diagnosis of Crohn's Disease or Ulcerative Colitis
- Patient of a Stanford Children's Health or Stanford-affiliated Pediatric Gastroenterologist
- Ability to attend in-person meetings/training
You may not qualify if:
- Initiation of biologic therapy in prior 3 months
- Hospital admission in prior 2 months
- Major surgery in prior 1 month
- PUCAI/PCDAI \>65
- Current pregnancy
- Severe developmental or intellectual disability
- Non-english speaking
- Not participating in another concurrent clinical trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lucile Packard Children's Hospital
Palo Alto, California, 94304, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ann Ming Yeh, MD
Clinician Educator at Stanford University
- PRINCIPAL INVESTIGATOR
Jenna Marie Arruda, MD, MPH
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 6, 2018
First Posted
February 17, 2021
Study Start
January 1, 2017
Primary Completion
May 31, 2017
Study Completion
May 31, 2017
Last Updated
February 17, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share